| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |